Stocktoria

Nuvalent, Inc. NUVL

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-07-29 · LEI

Nuvalent, Inc. statistics & valuation

Market cap$9.8B
P / B7.8×
Return on equity-34.1%
Return on capital-31.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-16.30% -17.70% -18.00% -24.40% -34.10% 202020212022202320242025
Shares outstanding
3.1M 21.8M 49.7M 58.2M 66.4M 72.7M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-136.70% -15.80% -17.00% -17.20% -22.80% -30.10% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$5.08 -$2.13 -$1.65 -$2.17 -$3.93 -$5.85 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-30.1%-22.8%-17.2%-17.0%-15.8%-136.7%
Return on equity-34.1%-24.4%-18.0%-17.7%-16.3%46.5%
Current ratio15.2720.9622.8324.5433.072.43

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.